In a new, bipartisan letter, 28 senators joined NRHA in requesting HHS Secretary Alex Azar to urge the Health Resources and HRSA to exercise its authority to protect the 340B Drug Pricing Program from ongoing attacks by pharmaceutical manufacturers. Earlier, on the other side of the Capitol, the House letter, led by Representatives McKinley and DeGette, was also sent to Secretary Azar. NRHA applauds the work done in both the House and Senate to defend and protect this invaluable lifeline. Their calls echo NRHA’s letter to Secretary Azar late last month.
